Effects of low-dose recombinant human brain natriuretic peptide on anterior myocardial infarction complicated by cardiogenic shock Reportar como inadecuado




Effects of low-dose recombinant human brain natriuretic peptide on anterior myocardial infarction complicated by cardiogenic shock - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

ZhiGang Lu ; Jingyu Hang ; Shixin Ma ; Jian Ma ; Meng Wei ;Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery 2017, 32 2

Autor: Yesheng Pan

Fuente: http://www.redalyc.org/articulo.oa?id=398950486007


Introducción



Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery ISSN: 0102-7638 revista@sbccv.org.br Sociedade Brasileira de Cirurgia Cardiovascular Brasil Pan, Yesheng; Lu, ZhiGang; Hang, Jingyu; Ma, Shixin; Ma, Jian; Wei, Meng Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock Revista Brasileira de Cirurgia Cardiovascular-Brazilian Journal of Cardiovascular Surgery, vol.
32, núm.
2, 2017, pp.
96-103 Sociedade Brasileira de Cirurgia Cardiovascular São José do Rio Preto, Brasil Available in: http:--www.redalyc.org-articulo.oa?id=398950486007 How to cite Complete issue More information about this article Journals homepage in redalyc.org Scientific Information System Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Non-profit academic project, developed under the open access initiative Braz J Cardiovasc Surg 2017;32(2):96-103 ORIGINAL ARTICLE Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock Yesheng Pan1, MD; ZhiGang Lu1, MD; Jingyu Hang1, MD; Shixin Ma1, MD; Jian Ma1, MD; Meng Wei1, MD DOI: 10.21470-1678-9741-2016-0007 Abstract control (n=23) groups.
In addition to standard therapy, study group individuals received rhBNP by continuous infusion at 0.005 μg kg−1 min−1 for 72 hours. Results: Baseline characteristics, medications, and peak of cardiac troponin I (cTnI) were similar between both groups.
rhBNP treatment resulted in consistently improved pulmonary capillary wedge pressure (PCWP) compared to the control group.
Respectively, 7 and 9 patients died in experimental and control groups.
No drug-related serious adverse events occurred in either group. Conclusion: When added to standard care in stable patients with cardiogenic shock complicating anterior STEMI, low dose rhBNP improves PCWP and is well tolerated. Keywords: Myocardi...





Documentos relacionados